Pheon Therapeutics
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist developing next-generation ADCs for hard-to-treat cancers. Their lead program targets a novel, highly-overexpressed target in solid tumors, demonstrating an unprecedented preclinical therapeutic index. The company aims to rapidly advance its ADC pipeline through clinical proof of concept.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $120M
Date: 21-May-2024
Investors: TCGX, BVF Partners, Lightspeed Venture Partners, Perceptive Advisors, Atlas Venture, Brandon Capital, Forbion, Research Corporation Technologies
Markets: Biotechnology, Oncology, Pharmaceuticals, Life Science, Medical, Therapeutics
HQ: Harpenden, Hertfordshire, United Kingdom
Founded: 2015
Website: https://www.pheontx.com/
LinkedIn: https://www.linkedin.com/company/pheon-therapeutics
Twitter: https://twitter.com/pheontx
Crunchbase: https://www.crunchbase.com/organization/pheon-therapeutics
Leave a Comment
Comments
No comments yet.